This announcement is a separate document:
中外製薬：2024年度第2四半期の中間連結財務諸表の補足資料。12（IFRS）
Chugai Pharmaceutical: Supplemental materials for the interim consolidated financial statements for the second quarter of fiscal year 2024. (IFRS 12)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated